Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
E.de Moraes Costa CarlesseF
Silas Hinsch Gylvin 6
2018;8 (JAN) (no pagination)(1974)
the non-H spelling reflects the Russian-language transliteration convention used in much of the originating Khavinson-laboratory work
Innovations in cancer therapy: Endogenous Stimuli-Responsive liposomes as advanced nanocarriers
US$ 26.17
US$ 23.03
US$ 20.07
